(IPO) for subscription today. The issue will close on June 20. The company aims to raise Rs 55.63 crore through a combination of fresh issue (Rs 45.07 crore) and an offer-for-sale (Rs 10.56 crore).The IPO is being offered in a price band of Rs 91 to Rs 96 per share. Investors can bid for a minimum of 1,200 shares It is proposed to list on the NSE SME platform, with a tentative listing date set for June 25.
Influx Healthtech operates in the health and wellness segment, offering a diverse range of services including product development and third-party manufacturing across nutraceuticals, cosmetics, ayurvedic products, and veterinary feed supplements.
The company’s facilities in Thane manufacture an expansive product portfolio ranging from tablets, gummies, and jellies to skincare and ayurvedic solutions.
The IPO proceeds will primarily be used for setting up two new manufacturing units in the nutraceutical and veterinary segments (Rs 34.19 crore), along with machinery purchases and general corporate purposes.
The company's revenue for FY25 stood at Rs 104.99 crore with a net profit of Rs 13.37 crore.(: Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of Economic Times)
